Cardiometabolic Health Congress
@CMHC_CME
Followers
2K
Following
6K
Statuses
5K
A resource for practicing clinicians, students, and patients interested in cardiometabolic health, CMHC offers up-to-date research, news, events, and more.
Boca Raton, Florida
Joined June 2010
💖 February is American Heart Month! 💖 Join us at the Cardiometabolic Health Congress for the latest heart health breakthroughs, innovative treatments, and expert insights! 🫀 Be sure to wear red tomorrow, February 7th for National Wear Red Day! ❤️ Register today! 🔗
0
0
0
After this activity, participants will be able to explain MAFLD/MASH pathogenesis, recognize screening tools, summarize treatment guidelines, review GLP-1 RA efficacy, and list emerging agents for MASH. #MAFLD #MASH #GLP1RA #CardiometabolicHealth 🔗
0
0
0
RT @CardiologyToday: Updates in new antiplatelet therapies, new patient populations for PCI and AI to guide CAD staging were among the top…
0
2
0
RT @CardiologyToday: At the Cardiometabolic Health Congress in October, @CBallantyneMD of @BCM_CVRI discussed recent developments in lipido…
0
2
0
RT @CardiologyToday: At #CMHC24, @DLBHATTMD of @MountSinaiHeart, discussed recent advances in thrombosis coronary disease management and an…
0
2
0
This 3-part series covers key cases on managing familial #hypercholesterolemia, #hyperlipidemia with cardiometabolic comorbidities, and #ASCVD risk in South Asian patients with a history of PCI. Quick cases, high-level takeaways! 🔗
0
0
0
#Atherosclerosis (#ASVD) remains a leading driver of cardiovascular disease (CVD), a global health challenge that claims millions of lives each year. But what if prevention could rewrite the narrative⁉️ 🔗
0
0
0
❓What do we know about the impact of iron deficiency on heart failure (#IDinHF)? ➡️Learn how it affects outcomes and why screening is crucial in managing patients with HF. 🔗 #CardioTwitter @CardioNerds @robmentz
0
1
4
Atherosclerosis—a key driver of cardiovascular disease (CVD)—continues to be a significant global health issue.🌐 This week, explore the growing burden of CVD, the rise of new risk factors, and barriers to prevention. 🔗
0
0
1
❓How do you identify and evaluate iron deficiency in heart failure (#IDinHF)? ➡️Want to hear more about it from the experts? Tune to this case-based podcast: #CardioTwitter
0
1
5
✨This activity consists of a recorded presentation at the 2024 Women's Health and Wellness Masterclass, held in April 2024 in Dana Point, CA. The symposium was presented by Pam R. Taub, MD, Erin D. Michos, MD, and Jennifer Green, MD. 🔗
0
0
1
RT @EndocrineToday: 📖Miss out on any of the biggest #obesity studies from 2024? We have you covered with this presentation from Robert Ecke…
0
3
0
CME COURSE➡️ ✨This activity consists of a recorded presentation at the 2024 Women's Health and Wellness Masterclass, held in April 2024 in Dana Point, CA. This session was presented by Debbie Cohen, MD. Click the link below to access the course! . 🔗
0
0
0
In this week’s CMHC Pulse Blog, we highlight the latest FDA-approved drugs and devices for cardiometabolic and cardiorenal conditions and risk factors. In 2024, the FDA granted new or expanded approval to 48 novel drugs and 28 devices, including a groundbreaking therapy for MASH and the only stent system FDA approved for treating infant vascular stenosis. Explore the full list of FDA novel drug approvals and their potential to improve patient care in this week’s blog. 🔗
0
0
0
RT @CardiologyToday: At @CMHC_CME in October, @kcferdmd highlighted advancements in hypertension care from 2024 @TulaneMedicine #Cardiotwit…
0
2
0